393 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Hanlon Investment Management Inc.

Hanlon Investment Management Inc. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 393 shares of the healthcare conglomerate’s stock, valued at approximately $200,000.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after purchasing an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after acquiring an additional 94,641 shares in the last quarter. Capital Research Global Investors raised its stake in shares of UnitedHealth Group by 2.2% during the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after acquiring an additional 324,733 shares in the last quarter. Capital International Investors grew its stake in UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock worth $6,244,158,000 after purchasing an additional 542,424 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $5,802,231,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of several recent research reports. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, August 30th. Barclays increased their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial boosted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Argus lifted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $614.17.

Insiders Place Their Bets

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

Shares of UNH stock opened at $596.88 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The firm has a market capitalization of $549.36 billion, a PE ratio of 36.48, a P/E/G ratio of 1.68 and a beta of 0.58. The stock’s 50-day simple moving average is $558.98 and its 200-day simple moving average is $515.11.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $6.14 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.41%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.